Left atrial size: physiologic determinants and clinical applications.

By W. Abhayaratna, James B. Seward, C. Appleton, P. Douglas, Jae K. Oh, A. Tajik, T. Tsang. Journal of the American College of Cardiology, 2006

1,129 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “LAVi >34 mL/m has been shown to be an independent predictor of death, heart failure, atrial fibrillation and ischaemic stroke [172].”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “LAVi>34mL/m(2) has been shown to be an independent predictor of death, heart failure, atrial fibrillation and ischaemic stroke [172].”
ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “LAVi ≥34 mL/m(2) has been shown to be an independent predictor of death, heart failure, atrial fibrillation and ischaemic stroke.(172)”
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. (2008, positive): “disease have shown that LA volume index 34 mL/m(2) is an independent predictor of death, heart failure, atrial fibrillation, and ischemic stroke.(12) However, one must recognize that dilated left atria may be seen in patients with bradycardia and 4-chamber enlargement, anemia and other high-output s”